Association between P16INK4a Promoter Methylation and Non-Small Cell Lung Cancer: A Meta-Analysis

Background Aberrant methylation of CpG islands acquired in tumor cells in promoter regions plays an important role in carcinogenesis. Accumulated evidence demonstrates P16INK4a gene promoter hypermethylation is involved in non-small cell lung carcinoma (NSCLC), indicating it may be a potential biomarker for this disease. The aim of this study is to evaluate the frequency of P16INK4a gene promoter methylation between cancer tissue and autologous controls by summarizing published studies. Methods By searching Medline, EMBSE and CNKI databases, the open published studies about P16INK4a gene promoter methylation and NSCLC were identified using a systematic search strategy. The pooled odds of P16INK4A promoter methylation in lung cancer tissue versus autologous controls were calculated by meta-analysis method. Results Thirty-four studies, including 2 652 NSCLC patients with 5 175 samples were included in this meta-analysis. Generally, the frequency of P16INK4A promoter methylation ranged from 17% to 80% (median 44%) in the lung cancer tissue and 0 to 80% (median 15%) in the autologous controls, which indicated the methylation frequency in cancer tissue was much higher than that in autologous samples. We also find a strong and significant correlation between tumor tissue and autologous controls of P16INK4A promoter methylation frequency across studies (Correlation coefficient 0.71, 95% CI:0.51–0.83, P<0.0001). And the pooled odds ratio of P16INK4A promoter methylation in cancer tissue was 3.45 (95% CI: 2.63–4.54) compared to controls under random-effect model. Conclusion Frequency of P16INK4a promoter methylation in cancer tissue was much higher than that in autologous controls, indicating promoter methylation plays an important role in carcinogenesis of the NSCLC. Strong and significant correlation between tumor tissue and autologous samples of P16INK4A promoter methylation demonstrated a promising biomarker for NSCLC.

• Publication year

  2013

• Venue

  PLoS ONE

• Publication date

  2013-04-05

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1371/journal.pone.0060107PMID 23577085PMCID 3618325
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Association between RUNX3 promoter methylation and non-small cell lung cancer: a meta-analysis.

  2014cited by this paper
• Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement

  2014cited by this paper
• Epigenetics and aging.

  2013cited by this paper
• Epigenetic susceptibility factors for prostate cancer with aging

  2013cited by this paper
• Cancer statistics, 2013

  2013cited by this paper
• Promoter hypermethylation in primary squamous cell carcinoma of the oral cavity and oropharynx: a study of a Brazilian cohort

  2012cited by this paper
• Clinical Potential of DNA Methylation in Gastric Cancer: A Meta-Analysis

  2012cited by this paper
• RUNX3 methylation in normal surrounding urothelium of patients with non-muscle-invasive bladder cancer: potential role in the prediction of tumor progression.

  2012cited by this paper
• Methylation of P16 and RASSF1A Genes in Sputum Samples Associated with Peripheral Non-Small Cell Lung Cancer

  2012cited by this paper
• Aberrant DNA methylation profile in pleural fluid for differential diagnosis of malignant pleural mesothelioma

  2012cited by this paper
• Application of RUNX3 gene promoter methylation in the diagnosis of non-small cell lung cancer.

  2012cited by this paper
• Impact of Reporting Bias in Network Meta-Analysis of Antidepressant Placebo-Controlled Trials

  2012cited by this paper
• RUNX3 Downregulation in Human Lung Adenocarcinoma is Independent of p53, EGFR or KRAS Status

  2012cited by this paper
• [RUNX3 promoter hypermethylation and prognosis of early surgically resected non-small cell lung cancers].

  2011cited by this paper
• Methylation of multiple genes as a candidate biomarker in non-small cell lung cancer.

  2011cited by this paper
• Inverse correlation between EGFR mutation and FHIT, RASSF1A and RUNX3 methylation in lung adenocarcinoma: relation with smoking status.

  2011cited by this paper
• Determination of O6-Methylguanine DNA Methyltransferase Promoter Methylation in Non-Small Cell Lung Cancer

  2011cited by this paper
• Aberrant DNA methylation of some tumor suppressor genes in lung cancers from workers with chromate exposure

  2011cited by this paper
• [Relationship between promoter methylation of p16, DAPK and RAR beta genes and the clinical data of non-small cell lung cancer].

  2011cited by this paper
• DNA methylation profile during multistage progression of pulmonary adenocarcinomas

  2011cited by this paper
• Cigarette Smoking and p16INK4α Gene Promoter Hypermethylation in Non-Small Cell Lung Carcinoma Patients: A Meta-Analysis

  2011cited by this paper
• Prevention of ventilator-associated pneumonia with oral antiseptics: a systematic review and meta-analysis.

  2011cited by this paper
• Global cancer statistics

  2011cited by this paper
• Significance of RUNX3 Hypermethylation in Serum DNA of Non-small Cell Lung Cancer Patients

  2011cited by this paper
• Cochrane Handbook for Systematic Reviews of Interventions

  2010cited by this paper
• Multiplexed methylation profiles of tumor suppressor genes and clinical outcome in lung cancer

  2010cited by this paper
• Lung tissue regeneration after induced injury in Runx3 KO mice

  2010cited by this paper
• Runx3 is required for the differentiation of lung epithelial cells and suppression of lung cancer

  2010cited by this paper
• Molecular Characterization of Chronic Obstructive Pulmonary Disease-Related Non-Small Cell Lung Cancer Through Aberrant Methylation and Alterations of EGFR Signaling

  2010cited by this paper
• Hypermethylation downregulates Runx3 gene expression and its restoration suppresses gastric epithelial cell growth by inducing p27 and caspase3 in human gastric cancer

  2010cited by this paper
• Cancer Epigenetics

  2010cited by this paper
• Epigenetics in cancer.

  2010cited by this paper
• Methylation of p16 gene in plasma and tissues from non-small cell lung cancer patients

  2010cited by this paper
• O(6)-Methylguanine-DNA methyltransferase expression and prognostic value in brain metastases of lung cancers.

  2010cited by this paper
• Different histological types of non‐small cell lung cancer have distinct folate and DNA methylation levels

  2009cited by this paper
• Analysis of promoter hypermethylation of Runx3 gene in non-small cell lung carcinoma

  2009cited by this paper
• RUNX3 Inactivation in Colorectal Polyps Arising Through Different Pathways of Colonic Carcinogenesis

  2009cited by this paper
• Promoter hypermethylation of multiple genes in early gastric adenocarcinoma and precancerous lesions.

  2009cited by this paper
• Current treatments for advanced stage non-small cell lung cancer.

  2009cited by this paper
• RASSF1A, APC, ESR1, ABCB1 and HOXC9, but not p16INK4A, DAPK1, PTEN and MT1G genes were frequently methylated in the stage I non-small cell lung cancer in China

  2009cited by this paper
• Promoter methylation primarily occurs in tumor cells of patients with non-small cell lung cancer.

  2009cited by this paper
• Commentary: Heterogeneity in meta-analysis should be expected and appropriately quantified.

  2008cited by this paper
• Lung cancer epigenetics and genetics

  2008cited by this paper
• DNA Methylation in Tumor and Matched Normal Tissues from Non-Small Cell Lung Cancer Patients

  2008cited by this paper
• Epigenetic alteration of Wnt pathway antagonists in progressive glandular neoplasia of the lung.

  2008cited by this paper
• The detection and clinical diagnostic value of promoter hypermethylation of p16 gene in serum and tissue of lung cancer patients

  2008cited by this paper
• Multiple gene methylation of nonsmall cell lung cancers evaluated with 3‐dimensional microarray

  2008cited by this paper
• Arcsine test for publication bias in meta‐analyses with binary outcomes

  2008cited by this paper
• Epigenetics in cancer.

  2008cited by this paper
• RUNX3 inactivation by frequent promoter hypermethylation and protein mislocalization constitute an early event in breast cancer progression

  2008cited by this paper
• Hypermethylation of p16INK4a in Korean Non-small Cell Lung Cancer Patients

  2007cited by this paper
• Promoter hypermethylation of RASSF1A and RUNX3 genes as an independent prognostic prediction marker in surgically resected non-small cell lung cancers.

  2007cited by this paper
• Characterization of a multiple epigenetic marker panel for lung cancer detection and risk assessment in plasma

  2007cited by this paper
• Multiple genetic and epigenetic biomarkers for lung cancer detection in cytologically negative sputum and a nested case–control study for risk assessment

  2007cited by this paper
• Detection of promoter hypermethylation in serum samples of cancer patients by methylation-specific polymerase chain reaction for tumour suppressor genes including RUNX3.

  2007cited by this paper
• Aberrant DNA methylation profiles of non-small cell lung cancers in a Korean population.

  2007cited by this paper
• Aberrant p16 promoter methylation among Greek lung cancer patients and smokers: correlation with smoking

  2007influential reference
• Predicting gene promoter methylation in non-small-cell lung cancer by evaluating sputum and serum

  2007cited by this paper
• Aberrant DNA methylation profiles of non-small cell lung cancers in a korean population

  2007cited by this paper
• A PRELIMINARY STUDY OF RADIOTHERAPEUTIC TARGET REGION DESIGN FOR NSCLC BY DETECTION OF p16 GENE METHYLATION

  2007cited by this paper
• Spreading of methylation within RUNX3 CpG island in gastric cancer

  2006cited by this paper
• RUNX3 is frequently inactivated by dual mechanisms of protein mislocalization and promoter hypermethylation in breast cancer.

  2006cited by this paper
• A Genome-Wide Screen for Promoter Methylation in Lung Cancer Identifies Novel Methylation Markers for Multiple Malignancies

  2006cited by this paper
• Methylation profile in tumor and sputum samples of lung cancer patients detected by spiral computed tomography: A nested case–control study

  2006cited by this paper
• Epigenetic inactivation of the RUNX3 gene in lung cancer.

  2006cited by this paper
• DNA methyltransferases messenger RNA expression and aberrant methylation of CpG islands in non-small-cell lung cancer: association and prognostic value.

  2006cited by this paper
• p16INK4A and CDH13 hypermethylation in tumor and serum of non‐small cell lung cancer patients

  2006cited by this paper
• Methylation of ASC and p16 genes in promoter region associated with genesis and progress of non-small cell lung cancer

  2006cited by this paper
• [Cancer epigenetics].

  2006cited by this paper
• Methylation Profiling of Archived Non–Small Cell Lung Cancer: A Promising Prognostic System

  2005cited by this paper
• Can aberrant promoter hypermethylation of CpG islands predict the clinical outcome of non-small cell lung cancer after curative resection?

  2005cited by this paper
• Frequent hemizygous deletion at 1p36 and hypermethylation downregulate RUNX3 expression in human lung cancer cell lines.

  2005cited by this paper
• DNA methylation-associated inactivation of TGFβ-related genes, DRM/Gremlin, RUNX3, and HPP1 in human cancers

  2005cited by this paper
• Hypermethylation of the RUNX3 gene in hepatocellular carcinoma

  2005cited by this paper
• Differential DNA Hypermethylation of Critical Genes Mediates the Stage-Specific Tobacco Smoke-Induced Neoplastic Progression of Lung Cancer

  2005cited by this paper
• Detection of Promoter Hypermethylation of Multiple Genes in the Tumor and Bronchoalveolar Lavage of Patients with Lung Cancer

  2004cited by this paper
• Transcriptional silencing of the RUNX3 gene by CpG hypermethylation is associated with lung cancer.

  2004cited by this paper
• Methylation of RUNX3 in various types of human cancers and premalignant stages of gastric carcinoma

  2004cited by this paper
• The study of p16 methylation and p16 protein expression in non-small cell lung cancers(NSCLC)

  2004cited by this paper
• Promoter Hypermethylation of Resected Bronchial Margins

  2004cited by this paper
• Tumor suppressor activity of RUNX3

  2004cited by this paper
• [Hypermethylation of p16 gene in clinical specimens of patients with lung cancer].

  2004cited by this paper
• Plutonium targets the p16 gene for inactivation by promoter hypermethylation in human lung adenocarcinoma.

  2004cited by this paper
• Age-related methylation of tumor suppressor and tumor-related genes: an analysis of autopsy samples

  2003cited by this paper
• Gene promoter hypermethylation in tumors and lymph nodes of stage I lung cancer patients.

  2003cited by this paper
• Promoter hypermethylation of tumor suppressor and tumor‐related genes in non‐small cell lung cancers

  2003cited by this paper
• Quantitative O(6)-methylguanine DNA methyltransferase methylation analysis in curatively resected non-small cell lung cancer: associations with clinical outcome.

  2003cited by this paper
• [MGMT expression and its relationship with efficacy of chemotherapy and prognosis in patients with non-small cell lung cancer].

  2003cited by this paper
• Hypermethylation of p16INK4a in Chinese lung cancer patients: biological and clinical implications.

  2003cited by this paper
• Measuring inconsistency in meta-analyses

  2003cited by this paper
• A Hypermethylation Detected by Fluorescent Methylation-specific PCR in Plasmas from Non-Small Cell Lung Cancer 1

  2002cited by this paper
• Tumor p16M is a possible marker of advanced stage in non–small cell lung cancer

  2002cited by this paper
• The fundamental role of epigenetic events in cancer

  2002cited by this paper
• Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer.

  2002cited by this paper
• p16(INK4A) Hypermethylation detected by fluorescent methylation-specific PCR in plasmas from non-small cell lung cancer.

  2002cited by this paper
• Alterations of the p16ink4a gene in resected nonsmall cell lung tumors and exfoliated cells within sputum

  2002cited by this paper
• Aberrant promoter methylation of multiple genes in non-small cell lung cancers.

  2001cited by this paper
• A gene hypermethylation profile of human cancer.

  2001cited by this paper
• Frequent allelic imbalance suggests involvement of a tumor suppressor gene at 1p36 in the pathogenesis of human lung cancers

  2000cited by this paper
• Frequent occurance of aberrant promoter methylation of either RARβ, TIMP-3, p16, MGMT, FHIT, DAPK, Ecad, p14 or GSTP1 in resected non-small cell lung cancers

  2000cited by this paper

• Prognostic Significance of Potential Target Networks and P16INK4a In Early Diagnosis of Non-Small Cell Lung Cancer

  2024cites this paper
• Epigenetic regulation in lung cancer

  2023influential citation
• Analyses of P16^INK4a gene promoter methylation relative to molecular, demographic and clinical parameters characteristics in non-small cell lung cancer patients: A pilot study

  2022cites this paper
• APC gene promoter methylation as a potential biomarker for lung cancer diagnosis: A meta‐analysis

  2021cites this paper
• Identification of prognostic signature of non–small cell lung cancer based on TCGA methylation data

  2020cites this paper
• Expression and role of p16 and GLUT1 in malignant diseases and lung cancer: A review

  2020cites this paper
• Clinical Significance of P16 Gene Methylation in Lung Cancer.

  2020cites this paper
• Correlation between RASSF1A, P16, DAP Kinase Promoter Hypermethylation and Lung Cancer: Relation with Smoking Status

  2020cites this paper
• Gene promoter methylation and cancer: An umbrella review.

  2019cites this paper
• Genetic and epigenetic alterations of the EGFR and mutually independent association with BRCA1, MGMT, and RASSF1A methylations in Vietnamese lung adenocarcinomas.

  2019cites this paper
• The correlation between Runx3 and bronchial asthma.

  2018cites this paper
• P16 INK4a gene promoter methylation as a biomarker for the diagnosis of non‐small cell lung cancer: An updated meta‐analysis

  2018cites this paper
• Functional Nucleic Acid Based Biosensors for DNA Methylation Detection

  2018cites this paper
• The Association Between MGMT Promoter Methylation and Patients with Gastric Cancer: A Meta-Analysis

  2017cites this paper
• Phytochemicals in Traditional Chinese Herbal Medicine: Cancer Prevention and Epigenetics Mechanisms

  2017cites this paper
• TRIM36 hypermethylation is involved in polycyclic aromatic hydrocarbons-induced cell transformation.

  2017cites this paper
• O6-Methylguanine-DNA methyltransferase (MGMT): A drugable target in lung cancer?

  2017cites this paper
• Does adenomatous polyposis coli gene promoter 1A methylation increase non‐small cell lung cancer risk? A meta‐analysis

  2017cites this paper
• Circulating epigenetic biomarkers in lung malignancies: From early diagnosis to therapy.

  2017cites this paper
• Combined treatment for non-small cell lung cancer and breast cancer patients with brain metastases with whole brain radiotherapy and temozolomide: a systematic review and meta-analysis

  2017cites this paper
• Clinical Epigenetics of Lung Cancer

  2017cites this paper
• Accurate and easy-to-use assessment of contiguous DNA methylation sites based on proportion competitive quantitative-PCR and lateral flow nucleic acid biosensor.

  2016cites this paper
• Common Pathways in IPF and Lung Cancer

  2016cites this paper
• Upconversion Nanoparticle-Based Förster Resonance Energy Transfer for Detecting DNA Methylation

  2016cites this paper
• Quantitative assessment of the diagnostic role of FHIT promoter methylation in non-small cell lung cancer

  2016cites this paper
• Aberrant methylation of CDH13 can be a diagnostic biomarker for lung adenocarcinoma

  2016cites this paper
• DNA methylation: its role in transcriptional regulation and association with lung cancer

  2015cites this paper
• A meta-analysis of serum p16 gene promoter methylation for diagnosis of nonsmall cell lung cancer.

  2015cites this paper
• Environmental Toxicants, Epigenetics, and Cancer

  2015cites this paper
• 5-azacytidine enhances efficacy of multiple chemotherapy drugs in AML and lung cancer with modulation of CpG methylation.

  2015cites this paper
• Aberrant methylation in promoter region induced silencing of P 16/NK4a in colorectal cancer in Iranian patients

  2014cites this paper
• Quantitative assessment of the diagnostic role of APC promoter methylation in non-small cell lung cancer

  2014cites this paper
• Epigenetic epidemiology of cancer.

  2014cites this paper
• Association of roasting meat intake with the risk of esophageal squamous cell carcinoma of Kazakh Chinese via affecting promoter methylation of p16 gene.

  2014cites this paper
• Demonstration program of population-based lung cancer screening in China: Rationale and study design

  2014cites this paper
• A Meta-Analysis of the Relationship Between RARβ Gene Promoter Methylation and Non-Small Cell Lung Cancer

  2014cites this paper